Description
Rufinamide metabolite-[d2] is a labelled metabolite of Rufinamide. Rufinamide (E 2080; CGP 33101; RUF 331) is a new antiepileptic agent that differs structurally from other antiepileptic drugs and is approved as adjunctive therapy for Lennox-Gastaut syndrome (LGS)